Detalhe da pesquisa
1.
Ustekinumab treatment for toxic megacolon in severe colonic Crohn's disease.
Rev Esp Enferm Dig
; 113(3): 189-192, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33244975
2.
Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
Gastroenterol Hepatol
; 42(9): 542-547, 2019 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31402179
3.
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).
Gastroenterology
; 159(2): 781-783, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330477
4.
[Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission]. / Evolución clínica tras la suspensión de infliximab en pacientes con colitis ulcerosa en remisión profunda.
Gastroenterol Hepatol
; 39(7): 442-8, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26948837
5.
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233844
6.
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
J Clin Med
; 11(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556155
7.
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
J Clin Med
; 10(13)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209680
8.
Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors.
Dig Liver Dis
; 50(8): 812-819, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625907
9.
Anticoagulation in a cirrhotic patient with acute portal vein thrombosis unrelated to malignancy. A case report.
Rev Esp Enferm Dig
; 104(3): 152-3, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449160
10.
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Inflamm Bowel Dis
; 22(4): 894-901, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933750
11.
[Prosthetic repair of perforation after endoscopic dilation in a patient with achalasia]. / Reparación mediante prótesis de una perforación tras dilatación endoscópica en un paciente con acalasia.
Gastroenterol Hepatol
; 29(9): 593, 2006 Nov.
Artigo
em Espanhol
| MEDLINE | ID: mdl-17129555
12.
Evolución clínica tras la suspensión de infliximab en pacientes con colitis ulcerosa en remisión profunda / Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission
Gastroenterol. hepatol. (Ed. impr.)
; 39(7): 442-448, ago.-sept. 2016. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-155184
13.
Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term / La inmunosupresión no modifica la carga viral del virus de Epstein-Barr a corto plazo en los pacientes con enfermedad inflamatoria intestinal
Gastroenterol. hepatol. (Ed. impr.)
; 42(9): 542-547, nov. 2019. tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-187915
14.
Anticoagulation in a cirrhotic patient with acute portal vein thrombosis unrelated to malignancy. A case report
Rev. esp. enferm. dig
; 104(3): 152-153, mar. 2012.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-99777
15.
Reparación mediante prótesis de una perforación tras dilatación endoscópica en un paciente con acalasia / Prosthetic repair of perforation after endoscopic dilation in a patient with achalasia
Gastroenterol. hepatol. (Ed. impr.)
; 29(9): 593-593, nov. 2006.
Artigo
em Es
| IBECS (Espanha) | ID: ibc-051005